Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02148276 · ClinicalTrials.gov registry record

Improving Identification of Social Harm Among Substance Abusers in HIV Trials

A clinical trial of Social Harms in Substance Users in HIV Trials and Audio Computer Assisted Self-administered Questionnaire, sponsored by Treatment Research Institute.

Completed
Registry status
79
Enrollment target
1
Study location

NCT02148276 is a study of Social Harms in Substance Users in HIV Trials and Audio Computer Assisted Self-administered Questionnaire that has completed, run by Treatment Research Institute. The registered enrollment target is 79 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02148276, a study of Social Harms in Substance Users in HIV Trials and Audio Computer Assisted Self-administered Questionnaire, has completed, sponsored by Treatment Research Institute.

COMPLETED
Registry status
79 participants
Enrollment target
1
Study location

Study Summary

This two-phased project will develop a comprehensive, audio computer assisted self-administered interview social harm questionnaire (ACASI-SHQ) that will allow researchers to more easily identify and monitor social harms experienced by substance abusers participating in HIV-related trials. The ACASI-SHQ will (1) reduce the likelihood of socially desirable responding, (2) include items with high levels of specificity to increase the likelihood of identifying social harms (construct validity), and (3) utilize a self-interview format that will increase the likelihood of its adoption by HIV researchers. The investigators will then evaluate its feasibility, acceptability, and preliminary utility and construct validity in an ongoing HIV-related trial.

Study Locations (1)

Pennsylvania

  • Treatment Research Institute - Philadelphia

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2015-05
Est. Completion 2017-04-04

Sponsor

Treatment Research Institute

18 total trials

What the Registry Record Tells You About NCT02148276

The ClinicalTrials.gov registry entry for NCT02148276 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Treatment Research Institute, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Social Harms in Substance Users in HIV Trials appearing as the primary indexed condition, and to 0 interventions.

NCT02148276 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02148276 about?

NCT02148276 is a clinical study titled "Improving Identification of Social Harm Among Substance Abusers in HIV Trials". This two-phased project will develop a comprehensive, audio computer assisted self-administered interview social harm questionnaire (ACASI-SHQ) that will allow researchers to more easily identify and monitor social harms experienced by substance abusers participating in HIV-related trials. The ACASI...

What is the current status of trial NCT02148276?

This trial is currently completed. The enrollment target is 79 participants. The study started on 2015-05. Estimated completion is 2017-04-04.

What conditions does trial NCT02148276 study?

This clinical trial studies the following conditions: Social Harms in Substance Users in HIV Trials, Audio Computer Assisted Self-administered Questionnaire.

Who is sponsoring clinical trial NCT02148276?

This trial is sponsored by Treatment Research Institute, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02148276 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.